Doctors are missing chances to diagnose COPD earlier
In up to 85 percent of cases. “The substantial numbers of patients misdiagnosed and under diagnosed in this study is a cause for concern. It is important that… read more.
In up to 85 percent of cases. “The substantial numbers of patients misdiagnosed and under diagnosed in this study is a cause for concern. It is important that… read more.
Enzyme’s role is to ‘throw away’ protein if it overstays its welcome during immune response. An enzyme that helps maintain immune system function by “throwing away” a specific… read more.
From the annual meeting of the British Transplantation Society in Glasgow by Marc J. Clancy. Since its establishment within the mainstream of clinical care, the technology of organ… read more.
by Bruce Sylvester – Pregnant women who take non-steroidal anti-inflammatory drugs do not increase their risk of miscarriages, researchers report in a study published on Feb. 3, 2014… read more.
by Bruce Sylvester – Children born preterm appear to have a higher risk of developing asthma and wheezing disorders, researchers report in a study published on Jan. 28,… read more.
Children who sleep less found to eat more. Young children who sleep less eat more, which can lead to obesity and related health problems later in life, reports… read more.
Common cholesterol-lowering drugs could provide relief to patients suffering from a chronic lung disease, a study has shown. Statins were found to help alleviate the chronic coughing associated… read more.
by Gary Finnegan: New research reveals that patients in Sweden have a better chance of surviving a heart attack than their UK counterparts.
by Gary Finnegan: A startling new study from the University of Adelaide shows that the state of South Australia has a higher rate of deaths from extreme cold… read more.
by Gary Finnegan: The European Medicines Agency (EMA) has recommended approval of several new medicines.
by Gary Finnegan – Medicines regulators have pledged closer transatlantic cooperation on medicine safety, building on earlier commitments to join forces on clinical trial site inspections.
by Gary Finnegan – The European drug regulator has given a paediatric-use marketing authorisation (PUMA) for Hemangiol to treat proliferation of infantile haemangioma.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.